This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Tokyo University of Science Foundation, Eci, Inc.. Active years: 2010-2026.
Company Filing History:
Years Active: 2010-2026
Title: Innovations by Yuya Terashima
Introduction
Yuya Terashima is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in cancer and inflammatory disease research. With a total of three patents to his name, Terashima's work focuses on innovative methods for predicting patient prognosis and developing therapeutic agents.
Latest Patents
One of Terashima's latest patents is a method for predicting the prognosis of patients with cancer or inflammatory diseases. This method involves measuring the expression level of the FROUNT gene in a sample collected from the patient. Since FROUNT is identified as a poor prognostic factor, lower expression levels indicate a better prognosis. Additionally, the method includes measuring the expression level of CC chemokine receptor/ligand genes, such as CCR2 or CCR5, which are good prognostic factors. Higher expression levels of these genes correlate with a better prognosis for the patient. Another significant patent involves an agent for controlling cells in the cancer or inflammatory microenvironment. This agent comprises components like disulfiram and its derivatives, which are used to inhibit interactions between specific proteins and enhance the efficacy of anticancer drugs.
Career Highlights
Throughout his career, Yuya Terashima has worked with esteemed organizations, including the Tokyo University of Science Foundation and Eci, Inc. His research has been pivotal in advancing the understanding of cancer biology and therapeutic strategies.
Collaborations
Terashima has collaborated with notable colleagues, including Kouji Matsushima and Etsuko Toda. Their joint efforts have contributed to the development of innovative solutions in the medical field.
Conclusion
Yuya Terashima's contributions to medical science through his patents and collaborations highlight his commitment to improving patient outcomes in cancer and inflammatory diseases. His innovative approaches continue to pave the way for future advancements in healthcare.